JP5758291B2 - Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素 - Google Patents

Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素 Download PDF

Info

Publication number
JP5758291B2
JP5758291B2 JP2011516843A JP2011516843A JP5758291B2 JP 5758291 B2 JP5758291 B2 JP 5758291B2 JP 2011516843 A JP2011516843 A JP 2011516843A JP 2011516843 A JP2011516843 A JP 2011516843A JP 5758291 B2 JP5758291 B2 JP 5758291B2
Authority
JP
Japan
Prior art keywords
lysin
bacteriophage lysin
seq
chimeric
chimeric bacteriophage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011516843A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011526920A (ja
JP2011526920A5 (cg-RX-API-DMAC7.html
Inventor
ビンセント エー. フィシェッティー,
ビンセント エー. フィシェッティー,
アヌ ダニエル,
アヌ ダニエル,
チャド ユーラー,
チャド ユーラー,
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University filed Critical Rockefeller University
Publication of JP2011526920A publication Critical patent/JP2011526920A/ja
Publication of JP2011526920A5 publication Critical patent/JP2011526920A5/ja
Application granted granted Critical
Publication of JP5758291B2 publication Critical patent/JP5758291B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
JP2011516843A 2008-07-03 2009-07-01 Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素 Expired - Fee Related JP5758291B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7827708P 2008-07-03 2008-07-03
US61/078,277 2008-07-03
PCT/US2009/049349 WO2010002959A2 (en) 2008-07-03 2009-07-01 A chimeric bacteriophage lysin with activity against staphylococci bacteria

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015033626A Division JP6169632B2 (ja) 2008-07-03 2015-02-24 Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素

Publications (3)

Publication Number Publication Date
JP2011526920A JP2011526920A (ja) 2011-10-20
JP2011526920A5 JP2011526920A5 (cg-RX-API-DMAC7.html) 2012-08-16
JP5758291B2 true JP5758291B2 (ja) 2015-08-05

Family

ID=41466590

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011516843A Expired - Fee Related JP5758291B2 (ja) 2008-07-03 2009-07-01 Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素
JP2015033626A Expired - Fee Related JP6169632B2 (ja) 2008-07-03 2015-02-24 Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015033626A Expired - Fee Related JP6169632B2 (ja) 2008-07-03 2015-02-24 Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素

Country Status (8)

Country Link
US (4) US8840900B2 (cg-RX-API-DMAC7.html)
EP (2) EP3263588A1 (cg-RX-API-DMAC7.html)
JP (2) JP5758291B2 (cg-RX-API-DMAC7.html)
AU (2) AU2009266982B2 (cg-RX-API-DMAC7.html)
CA (2) CA2984933C (cg-RX-API-DMAC7.html)
ES (1) ES2627321T3 (cg-RX-API-DMAC7.html)
HK (1) HK1248722A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010002959A2 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008018854A2 (en) 2005-06-06 2008-02-14 The Rockefeller University Bactiophage lysins for bacillus anthracis
CN101297034A (zh) 2005-08-24 2008-10-29 洛克菲勒大学 Ply-gbs突变溶素
MX383544B (es) 2011-04-21 2025-03-14 Univ Rockefeller Lisinas de bacteriofago de streptococcus para la deteccion y tratamiento de bacterias gram positivas
DK3085777T3 (da) 2011-05-04 2020-02-03 Micreos Human Health Bv Polypeptid
CA2851270C (en) 2011-10-05 2023-03-14 The Rockefeller University Dimeric bacteriophage lysins
RU2646102C2 (ru) * 2012-05-09 2018-03-01 Контрафект Корпорейшн Предотвращение, разрушение и обработка биопленки лизином бактериофага
AU2013259512B2 (en) 2012-05-09 2018-01-25 Contrafect Corporation Bacteriophage lysin and antibiotic combinations against gram positive bacteria
CN103122347B (zh) * 2013-02-01 2015-04-22 中国科学院武汉病毒研究所 一种杀灭葡萄球菌的裂解酶及其应用
ES2525954B1 (es) * 2013-05-28 2015-10-23 Consejo Superior De Investigaciones Científicas (Csic) Enzibióticos bactericidas mejorados frente a neumococo y otras bacterias
CN104762285B (zh) * 2015-04-23 2017-10-27 武汉菲吉乐科生物科技有限公司 一种自内裂解大肠杆菌的裂解酶及其应用
CN104805066B (zh) * 2015-05-18 2018-04-24 武汉菲吉乐科生物科技有限公司 一种葡萄球菌裂解酶及其应用
CN109152822B (zh) 2016-05-12 2023-12-05 抗非特公司 用于评估和确定抗菌多肽的最小抑制浓度的肉汤微量稀释法
MX2020013935A (es) * 2018-06-22 2021-03-09 Contrafect Corp Lisinas y sus derivados que resensibilizan staphylococcus aureus y bacterias gram positivas a antibioticos.
CA3108051A1 (en) * 2018-08-10 2020-02-13 Meiji Seika Pharma Co., Ltd. Bacteriophage preparation
CN109666667A (zh) * 2019-01-22 2019-04-23 上海交通大学 杀灭金黄色葡萄球菌的嵌合酶抗生素及其制备和应用
EP4051243A4 (en) * 2019-10-31 2023-11-01 Bactoclear Holdings Pte. Ltd. CHIMERIC PROTEINS FOR SELECTIVE LYSIS OF BACTERIA
AU2021231914A1 (en) * 2020-03-06 2022-11-03 Endolytix Technology, Inc. Compositions and methods for the treatment of intracellular bacterial infections
WO2021180892A1 (en) * 2020-03-11 2021-09-16 Telum Therapeutics S.L. New recombinant lysin and its use in the treatment of gram-negative bacterial infections
CN111808837A (zh) * 2020-07-17 2020-10-23 青岛诺安百特生物技术有限公司 一种金黄色葡萄球菌噬菌体裂解酶及其制备方法和应用
CN115820616A (zh) * 2022-07-22 2023-03-21 昆明理工大学 一种带荧光标记的噬菌体裂解酶及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997008553A1 (en) * 1995-08-22 1997-03-06 The Regents Of The University Of California Targeting of proteins to the cell wall of gram-positive bacteria
US6056954A (en) * 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6703025B1 (en) * 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US20020127215A1 (en) * 1999-09-14 2002-09-12 Lawrence Loomis Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
US20040213765A1 (en) * 2001-07-13 2004-10-28 Vincent Fischetti Use of bacterial phage associated lytic enzymes to prevent food poisoning
CN1643139A (zh) * 2002-03-25 2005-07-20 沃里克大学 抗菌剂
JPWO2004020635A1 (ja) * 2002-08-28 2005-12-15 株式会社テクノネットワーク四国 バクテリオファージおよび細菌感染症治療剤
CN101297034A (zh) * 2005-08-24 2008-10-29 洛克菲勒大学 Ply-gbs突变溶素
CN101952424A (zh) * 2007-08-22 2011-01-19 海格罗斯投资有限责任公司 用于人类和动物葡萄球菌感染的新蛋白
JP5732397B2 (ja) * 2008-10-10 2015-06-10 ルソメディカメンタ, エス.エー.Lusomedicamenta, S.A. 抗菌性ファージペプチド及びその使用法
ES2761835T3 (es) * 2009-02-06 2020-05-21 Technophage Investig E Desenvolvimento Em Biotecnologia Sa Fagos antibacterianos, péptidos de fagos y métodos de uso de los mismos

Also Published As

Publication number Publication date
CA2984933A1 (en) 2010-01-07
US11015182B2 (en) 2021-05-25
CA2729160A1 (en) 2010-01-07
JP2011526920A (ja) 2011-10-20
EP2307557A2 (en) 2011-04-13
US20190055533A1 (en) 2019-02-21
EP3263588A1 (en) 2018-01-03
EP2307557B1 (en) 2017-03-01
JP2015126738A (ja) 2015-07-09
CA2984933C (en) 2020-07-07
ES2627321T3 (es) 2017-07-27
US20150064156A1 (en) 2015-03-05
US11827911B2 (en) 2023-11-28
US20120258088A1 (en) 2012-10-11
HK1248722A1 (en) 2018-10-19
WO2010002959A3 (en) 2010-05-06
AU2015230807B2 (en) 2017-07-27
CA2729160C (en) 2017-11-14
EP2307557A4 (en) 2012-04-11
WO2010002959A2 (en) 2010-01-07
US10053681B2 (en) 2018-08-21
AU2009266982B2 (en) 2015-06-25
US20210348146A1 (en) 2021-11-11
US8840900B2 (en) 2014-09-23
AU2015230807A1 (en) 2015-10-15
JP6169632B2 (ja) 2017-07-26
AU2009266982A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
US11827911B2 (en) Chimeric bacteriophage lysin with activity against Staphylococci bacteria
Hermoso et al. Taking aim on bacterial pathogens: from phage therapy to enzybiotics
Borysowski et al. Bacteriophage endolysins as a novel class of antibacterial agents
HK1244503A1 (zh) 用於革兰氏阳性菌检测和治疗的链球菌属细菌噬菌体溶素
JP2023103347A (ja) 血液成分による溶菌タンパク質の抗菌活性の強化、並びにその方法及び使用
AU2018203076B2 (en) Dimeric bacteriophage lysins
JP6875756B2 (ja) 抗細菌ポリペプチドの最小発育阻止濃度を評価および決定するための微量液体希釈方法
US20180353575A1 (en) Clostridium difficile bacteriophage lysins for detection and treatment of clostridium difficile bacteria infection
Borysowski et al. Enzybiotics and their potential applications in medicine
Shang Structure-Guided Engineering of a Multimeric Bacteriophage-Encoded Endolysin PlyC
HK1259718A1 (zh) 用於革兰氏阳性菌检测和治疗的链球菌属细菌噬菌体溶素
HK1259586A1 (en) Dimeric bacteriophage lysins
HK1260296B (en) Dimeric bacteriophage lysins
HK1260296A1 (en) Dimeric bacteriophage lysins

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120628

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120628

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131126

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140224

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140303

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140325

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140401

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140409

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141024

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150123

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150224

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150507

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150603

R150 Certificate of patent or registration of utility model

Ref document number: 5758291

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees